Schizophrenia Study Suggests Advanced Genetic Scorecard Cannot Predict a Patient’s Fate

Researchers at the Icahn School of Medicine at Mount Sinai found that a tool commonly used in research for evaluating a person’s genetic risk for a disease, called a polygenic risk score, was no better at predicting the outcome of a schizophrenia patient’s disease over time than written reports. The results raise important questions about the use of polygenic risk scores in real-world, clinical situations, and also suggest that a doctor’s written report may be an untapped source of predictive information.

From mathematics to medicine: Wayne State medical school and mathematics faculty team up to apply complex mathematics to analyze fMRI data

Research led by a Wayne State University Department of Mathematics professor is aiding researchers in Wayne State’s Department of Psychiatry and Behavioral Neurosciences in analyzing fMRI data. fMRI is the preeminent class of signals collected from the brain in vivo and is irreplaceable in the study of brain dysfunction in many medical fields, including psychiatry, neurology and pediatrics.

Virginia Tech scientists tie improved learning processes to reduced symptoms of depression

In a Journal of the American Medical Association Psychiatry study led by Pearl Chiu and Brooks King-Casas of the Fralin Biomedical Research Institute at VTC, brain imaging and mathematical modeling reveal previously unreported mechanistic features of symptoms associated with major depressive disorder.

Does cannabis affect brain development in young people with ADHD? Too soon to tell, reports Harvard Review of Psychiatry

At least so far, the currently limited research base does not establish that cannabis has additional adverse effects on brain development or functioning in adolescents or young adults with attention-deficit/hyperactivity disorder (ADHD), concludes a review in the July/August issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Laughing gas relieves symptoms in people with treatment-resistant depression

Researchers at Washington University School of Medicine in St. Louis and the University of Chicago have found that a single, one-hour treatment that involves breathing in a mixture of oxygen and the anesthetic drug nitrous oxide — otherwise known as laughing gas — can significantly improve symptoms in people with treatment-resistant depression.

ASU health economist studies effects of mental illness disclosure in the workplace

A person with a serious mental illness must confront the difficult decision of whether to reveal their disorder in their workplace. Disclosing their diagnosis might create stigma, but it could also mean additional support. Adding to the delicate balancing act…

‘Breaking the links’ in the chain of violence: Journal of Psychiatric Practice continues series on therapeutic risk management approach

With mass shootings and other seemingly meaningless acts of violence in the headlines all too frequently, strategies to assess the risk and reduce the potential for violent acts are sorely needed. The fourth in a series of five columns devoted to therapeutic risk management of violence – focusing on a method called chain analysis to identify and target pathways leading to violent thoughts and behaviors – appears in the May issue of the Journal of Psychiatric Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Rutgers Champion of Student Health and Wellness is Retiring

When Melodee Lasky joined Rutgers University 19 years ago, behavioral and mental health services were scattered across the individual colleges with little coordination. Psychiatry and the Alcohol and Other Drug Assistance Program were part of student health, but counseling services were separated and college-affiliated. Lasky, a physician who recognized the connection between physical and emotional wellness, recommended that mental and behavioral health be integrated within the framework of student health. That led to the creation of CAPS – Counseling, Alcohol and Other Drug Assistance Program & Psychiatric Services – a program that helps about 4,500 students each year.

No increase in brain health problems in middle age for men who played football in high school

Decades after their days on the gridiron, middle-aged men who played football in high school are not experiencing greater problems with concentration, memory, or depression compared to men who did not play football, reports a study in Clinical Journal of Sport Medicine. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Blood test for depression, bipolar disorder offers promise of personalized treatment

Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime.
While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis of mood disorders and offers a promising blood test aimed at a precision-medicine approach to treatment.

Childhood Car Crash Inspires UC San Diego Alumni to Donate to Pediatric Research

UC San Diego alumni make a gift of $1 million towards first-of-its-kind pediatric research. The Cathy and Richard Tryon Pediatric Facial/Psychological Trauma Research Fund will support research at UC San Diego to benefit pediatric patients who have suffered from traumatic facial deformities.

Wayne State developing statewide mental health program to address stress among first responders and their families

The Wayne State University Department of Psychiatry and Behavioral Health Sciences has teamed with the State of Michigan to develop a comprehensive behavioral and mental health training and support program for the state’s first responders and their families to address the stress they face in their duties protecting residents.

Mental health app equally effective, half the cost

Digital mental health apps and internet-based treatments could overcome both access problems and provider shortages. But these apps have yet to be adopted in the U.S. healthcare system. One reason is that these apps need payment and reimbursement models that would enable broad adoption.

Researchers at the University of Washington School of Medicine recently published results to help propel policymakers to create these payment models. They proved that an app to help people with serious mental illness was just as effective as a clinic-based group intervention for half the cost.

Dr. Jill RachBeisel, Appointed Chair of the Department of Psychiatry at the UM School of Medicine

University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been appointed to serve as the Chair of the Department of Psychiatry, effective immediately. Dr. RachBeisel has served as the Department’s Interim Chair for the past two years and was previously Acting Chair and Vice Chair of the Department.

Brain & Behavior Research Foundation Receives $8 Million Bequest from Philanthropist and Mental Health Advocate Stephen Lieber

The Brain & Behavior Research Foundation today announced that is has received a bequest of $8 million from the noted philanthropist and mental health advocate Stephen Lieber. The Foundation is the world’s largest private funder of mental health research grants, and this gift will be used to expand its support for research that is transforming the lives of people living with mental illness.

Increase in pleasurable effects of alcohol over time can predict alcohol use disorder

A new study out of the University of Chicago Medicine following young adult drinkers for 10 years has found that individuals who reported the highest sensitivity to alcohol’s pleasurable and rewarding effects at the start of the trial were more likely to develop an alcohol use disorder (AUD) over the course of the study.

New paper proposes framework for eliminating defects in psychiatric care

A new paper from University Hospitals Cleveland Medical Center proposes a framework for eliminating defects in behavioral health treatment.
The authors cite that a large majority of defects are the result of system failures rather than due to the individual psychiatrist, and they propose that psychiatrists need to function as “systems engineers” to help eliminate these defects in healthcare organizations.

Mindfulness interventions can change health behaviors – Integrated model helps to explain how they work

A growing body of evidence supports the effectiveness of mindfulness approaches to promote positive changes in health behaviors. New neurobiologically based models of “mindful self-regulation” help to explain the how mindfulness-based interventions (MBIs) work to help people make healthy behavior changes, according to a review in the November/December issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.